Strides Arcolab is currently trading at Rs. 678.00,
up by 11.35 points or 1.70% from its previous closing of Rs. 666.65 on
the BSE.
The scrip opened at Rs. 672.75 and has
touched a high and low of Rs. 691.90 and Rs. 668.80 respectively. So far
75567 shares were traded on the counter.
The BSE
group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs.
1050.00 on 05-Dec-2013 and a 52 week low of Rs. 343.80 on 26-Feb-2014.
Last
one week high and low of the scrip stood at Rs. 691.90 and Rs. 662.00
respectively. The current market cap of the company is Rs. 4050.46
crore.
The promoters holding in the company stood
at 27.67% while Institutions and Non-Institutions held 46.79% and 25.54%
respectively.
Strides Arcolab has reported a net
profit after tax of Rs 338.47 crore for the quarter under review as
compared to Rs 2.21 crore for the same quarter in the previous year.
Total income of the company has increased by 8.24% at Rs 244.04 crore
for Q2FY15 as compared Rs 225.47 crore for the corresponding quarter
previous year.
Strides Arcolab is a global
pharmaceutical company headquartered in Bangalore, India that develops
and manufactures wide range of IP-lead niche pharmaceutical products
with an emphasis on sterile injectables.
No comments:
Post a Comment